JSM2023
Back to all people

Jared Lunceford

Merck & Co., Inc.
2 appearances in the program

Sessions & presentations

Innovative Approaches to Oncology Clinical Trials
Presentation: Approaches to handling missing response data at IA for estimating biomarker clinical utility
Contributed Papers · Sun, Aug 6 , 2:00 PM
Co-Author
Biomarkers in Clinical Trials - Statistical Applications
Presentation: Estimating Treatment Effects Across Clinical Trials
Contributed Papers · Tue, Aug 8 , 10:30 AM
Co-Author
↑